74508 Characteristics Influencing the Prevention of Psoriatic Arthritis With Secukinumab in Patients With Moderate to Severe Plaque Psoriasis: 5-Year Real-World Results From the SERENA Study
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB93
DOI: 10.1016/j.jaad.2026.04.381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Matthias Augustin und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Augustin, M., Kiltz, U., Sfikakis, P., Gullick, N., Lespessailles, E., Jürgens, J. B., Vizcaya, C., Clemens, A., Bao, W., & Ioannides, D. (2026). 74508 Characteristics Influencing the Prevention of Psoriatic Arthritis With Secukinumab in Patients With Moderate to Severe Plaque Psoriasis: 5-Year Real-World Results From the SERENA Study. Journal of the American Academy of Dermatology, 95(1), AB93. https://doi.org/10.1016/j.jaad.2026.04.381
Vancouver
Augustin M, Kiltz U, Sfikakis P, Gullick N, Lespessailles E, Jürgens JB, et al. 74508 Characteristics Influencing the Prevention of Psoriatic Arthritis With Secukinumab in Patients With Moderate to Severe Plaque Psoriasis: 5-Year Real-World Results From the SERENA Study. Journal of the American Academy of Dermatology. 2026;95(1):AB93. doi:10.1016/j.jaad.2026.04.381
BibTeX
@article{Augustin2026,
author = {Augustin, Matthias and Kiltz, Uta and Sfikakis, Petros and Gullick, Nicola and Lespessailles, Eric and Jürgens, Jan Brandt and Vizcaya, Cynthia and Clemens, Andreas and Bao, Weibin and Ioannides, Dimitrios},
title = {74508 Characteristics Influencing the Prevention of Psoriatic Arthritis With Secukinumab in Patients With Moderate to Severe Plaque Psoriasis: 5-Year Real-World Results From the SERENA Study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB93},
doi = {10.1016/j.jaad.2026.04.381}
}
EUVIMED